1. Home
  2. ARQT vs DRH Comparison

ARQT vs DRH Comparison

Compare ARQT & DRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

SELL

Current Price

$27.14

Market Cap

3.3B

Sector

Health Care

ML Signal

SELL

Logo Diamondrock Hospitality Company

DRH

Diamondrock Hospitality Company

SELL

Current Price

$14.56

Market Cap

3.0B

Sector

Real Estate

ML Signal

SELL

Company Overview

Basic Information
Metric
ARQT
DRH
Founded
2016
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.0B
IPO Year
2020
2004

Fundamental Metrics

Financial Performance
Metric
ARQT
DRH
Price
$27.14
$14.56
Analyst Decision
Buy
Buy
Analyst Count
8
14
Target Price
★ $40.38
$14.69
AVG Volume (30 Days)
2.4M
★ 3.0M
Earning Date
11-04-2026
11-03-2026
Dividend Yield
N/A
★ 3.06%
EPS Growth
88.79
★ 144.44
EPS
0.09
★ 0.67
Revenue
$376,072,000.00
★ $1,120,491,000.00
Revenue This Year
$44.19
$3.36
Revenue Next Year
$29.31
$2.37
P/E Ratio
$314.67
★ $21.49
Revenue Growth
★ 91.34
N/A
52 Week Low
$19.30
$8.57
52 Week High
$34.80
$14.85

Technical Indicators

Market Signals
Indicator
ARQT
DRH
Relative Strength Index (RSI) 44.15 61.72
Support Level $25.08 $13.88
Resistance Level $28.54 N/A
Average True Range (ATR) 1.58 0.35
MACD -0.48 -0.04
Stochastic Oscillator 19.64 65.46

Price Performance

Historical Comparison
ARQT
DRH

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

About DRH Diamondrock Hospitality Company

Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The company operates in one reportable segment: The hotel ownership segment, which is comprised of upper upscale and luxury chain scale hotels that offer hotel rooms, food and beverage and other ancillary guest services.

Share on Social Networks: